Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 14, 2011 Cindy Johnson	Simcere Pharmaceutical Shares Plunged: What You Need to Know Simcere Pharmaceutical Group dropped 10% in intraday trading today as investors continued to doubt the financial health of U.S.-listed Chinese companies.
The Motley Fool July 11, 2007 Brian Lawler	Not All Pharmaceutical Markets Are the Same The case of China's former FDA leader highlights the issues facing the country's pharmaceutical industry. Investors, take note.
The Motley Fool December 27, 2007 Brian Orelli	Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there.
The Motley Fool November 12, 2009 Brian Orelli	How Do You Say 'Drug Development' in Mandarin? Drug giant Novartis announces that it's heading to China in a big way.
Chemistry World July 13, 2007 Hepeng Jia	Chinese Legislation to Increase Drug Safety A long-awaited amendment to China's drug registration system is expected to discipline the country's medical sector and boost the pharmaceutical industry.
Chemistry World August 10, 2007 Hepeng Jia	China Invests More Than $1 Billion in Drug Safety In a bid to improve its food and drug safety, China has announced it will invest 8.8 billion yuan (US$1.16 billion) in the coming four years to improve its food and drug inspection and monitoring infrastructure.
Chemistry World October 11, 2007 Hepeng Jia	China's Drug Industry Set to Take Off Producing cheap drugs for the developing world could allow Chinese pharmaceutical firms to capture a bigger share of the international market, industry experts suggest.
Chemistry World May 18, 2007 Hepeng Jia	China's Battle with Fake Drugs While China's pharmaceutical industry is experiencing rapid growth, a boom in counterfeit drugs is costing human lives and eroding the public's confidence in medical products.
Chemistry World January 15, 2008 Hepeng Jia	Huge Project to Boost Chinese Drug Development The Chinese government has agreed a multi-billion drug development funding program to boost innovation in its generics-dominated pharmaceutical sector.
The Motley Fool February 12, 2007 Brian Lawler	I Love Drug Stocks This Valentine's Day, leave a special place in your heart for drug stocks.
The Motley Fool December 13, 2004 Brian Gorman	Which Medications Are Your Best Bets? Consumer Reports' effort to rate drugs offers a marketing lesson to pharmaceutical companies.
The Motley Fool March 15, 2007 Brian Lawler	It's All Good for Drugmakers With the whole drug industry growing so strongly, those looking for a safe place to park their investing dollars would be smart to take a look at some of the largest generic drugmakers.
The Motley Fool November 27, 2006 Brian Lawler	Pharmaxis Gets Good News From the FDA Fast-track designation gives this pharmaceutical stock a bump.
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
The Motley Fool March 15, 2004 W.D. Crotty	60 Minutes on Drugs Will the weekly news magazine's prime-time slam rattle the drug stocks?
The Motley Fool October 29, 2009	Today's 5-Star Movers Today's top-moving stocks from the Motley Fool five-star stock list: Kaydon Corp... Akamai...
The Motley Fool March 6, 2009 Brian Orelli	For Drug Companies, R&D Is Spelled C-R-O It seems likely that more and more pharma companies will try to get more bang for their bucks by spending them on research and development done outside the company, outsourcing it to clinical research organizations.
The Motley Fool August 27, 2009 Brian Orelli	The List You Have to Be On Good for you if your company's products made the cut in China. This sounds like a growth opportunity for American Oriental Bioengineering and anyone else who can get a place on the list.
Salon.com October 31, 2002 Arianna Huffington	Drugging our children the legal way America's legal drug pushers are free to offer kids their potent concoctions without having to prove they're safe or effective.
Chemistry World December 2009	Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs
The Motley Fool July 25, 2008 Dan Dzombak	3 Stocks Hitting High Notes These stocks are bucking the trend.
The Motley Fool June 29, 2010 Jim Royal	A Great Global Stock With a Free Kicker Find absolutely solid Chinese companies that are thriving now and will continue to thrive if and when the renminbi appreciates.
The Motley Fool June 16, 2009	Today's 5-Star Movers A list of today's top-moving stocks from the Motley Fool five-star stock list.
The Motley Fool July 20, 2010 Brian Orelli	Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant.
The Motley Fool September 11, 2009	Today's 5-Star Movers A list of today's top-moving stocks from the Motley Fool five-star stock list.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
The Motley Fool April 7, 2009	Today's 5-Star Movers A list of today's top moving stocks from the Motley Fool five-star stock list.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
BusinessWeek March 4, 2010 Frederik Balfour	The Ka-Ching in China Luring Medical Giants GE, Siemens, and others are angling for a piece of the $125 billion Beijing plans to spend on health care.
Chemistry World March 16, 2007	Testing Times for 'Mega-Pharma' A stern warning and gloomy forecast were delivered to the pharmaceutical industry at the Drug Discovery and Technology Summit in London.
Managed Care June 2005 John Carroll	UnitedHealth Stakes Claims On New Drug Safety Program One of the nation's largest health insurers will analyze claims to discover unintended effects of new drugs on its members.
The Motley Fool April 16, 2010 Jim Royal	A Great Global Stock With a Free Kicker Rising global pressure may force China to act. A great strategy is to find absolutely solid Chinese companies that are thriving now and will continue to thrive if and when the renminbi appreciates.
Bio-IT World July 11, 2002 Kevin Davies	Counting the Cost of Drug Discovery Much of the trouble ensnaring the drug industry is blamed on the exorbitant cost of drug discovery. Tangible proof that the bio-IT revolution will economize drug discovery is emerging, but there is still a long way to go.
Reason May 2003 Sara Rimensnyder	Cosmetic Surgery Public dissatisfaction with the war on drugs is mounting, putting federal warriors under increasing pressure to cut an enforcement and treatment budget that has ballooned. But rather than actually spend less, the administration hopes to rely on some Enron-style creative bookkeeping.
Pharmaceutical Executive March 1, 2013	China and the Emerging Markets Challenge: Why Big Pharma Must Embrace a New Strategy With health reform already tagged as a key domestic priority, their policies will pose new opportunities and challenges for Big Pharma companies active in China.
The Motley Fool April 27, 2009	Today's 5-Star Movers A list of today's top-moving stocks from the Motley Fool five-star stock list.
Salon.com April 20, 2001 Arianna Huffington	The drug companies' racket Pharmaceutical giants are finally bending to worldwide public pressure on AIDS drugs, but we're still victims of their profiteering...
Reason November 2004 Jacob Sullum	Fluid Check A British inquiry into drug testing in the workplace finds the practice ineffective as a deterrent effect on drug use.
The Motley Fool December 11, 2006 Michael P. Cecil	Why Doesn't Buffett Buy Drug Companies? Investors, how do you estimate the amount of money that a drug company, or perhaps more simply one of its drugs, will produce over its lifetime?
The Motley Fool August 2, 2004 Charly Travers	What's a Drug Worth? The value of small biotech companies is in their investigational drug programs.
The Motley Fool June 29, 2009 Brian Orelli	Funding From an Unlikely Place Nonprofits still have money, and they seem willing to fork it over to for-profit drug companies.
The Motley Fool May 28, 2004 Charly Travers	Don't Be a Biotech Gambler Stand on solid ground by learning to assess the value of future drug programs. Investing in biotechs -- rather than simply speculating in the sector -- requires a solid assessment of how much a company's drug programs could be worth.
On Wall Street February 1, 2012 Dave Lindorff	Finding the Safe Bet in China "Things are amazing in China," exclaims an enthusiastic Sean Lynch, global investment strategist for Wells Fargo Private Bank.
Salon.com January 17, 2001 Dawn MacKeen	Could Ashcroft roll back drug policy reform? Bush's choice for attorney general might halt efforts to emphasize treatment over incarceration, opponents fear...
Reason July 2005 Jacob Sullum	Heresy on the Right Conservatives and the drug war: an independent policy analyst's report does not advocate the repeal of prohibition in the U.S., but it does reject central aspects of the drug policy status quo.